Research Article |
Corresponding author: Amjad I. Oraibi ( amjadibrahim@uomanara.edu.iq ) Academic editor: Lily Peikova
© 2024 Muthanna Saadi Farhan, Farrah Rasool Jaafar, Amjad I. Oraibi.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Farhan MS, Jaafar FR, Oraibi AI (2024) Unveiling the dual anti-viral and anti-bacterial potential of Tridax procumbens: integrating system biology and molecular modeling for therapeutic insights. Pharmacia 71: 1-14. https://doi.org/10.3897/pharmacia.71.e134884
|
This study evaluates the dual anti-viral and anti-bacterial activity of Tridax procumbens using system biology and molecular docking targeting the tumor necrosis factor (TNF) signaling pathway. The bioactive potential of Tridax procumbens was studied using phytochemical databases, and the essential biomolecules were selected for the study. The principle of geneVenn diagrams and protein target prediction was used to identify overlapping molecular targets with viral and bacterial diseases, which was later validated using various database mining tools like GeneCards and OMIM. Cytoscape software was applied to construct protein-protein interaction networks, which showed that TNF, AKT1, EGFR, SRC, and ESR1 are the hub genes of the networks. The gene ontology (GO) enrichment analysis also recapitulated the modulated biological processes, cellular components, and molecular functions of Tridax procumbens compounds, including their action on the TNF signaling in inflammation and immune responses. Molecular docking studies showed strong binding affinities of compounds such as cynaroside and 5,7,2,3,4-Pentahydroxy-3,6-dimethoxyflavone 7-glucoside to TNF, and molecular dynamics simulations confirmed these interactions’ stability. The findings suggest that Tridax procumbens exerts its therapeutic effects by modulating the TNF signaling pathway, offering significant anti-viral and anti-bacterial properties. This integrative approach provides insights into the Tridax procumbens’s mechanisms of action, supporting its potential as a source of novel therapeutic agents against infectious and bacterial diseases. There is still a need for further experimental research to define the full spectrum of Tridax procumbens’ therapeutic application.
Tridax procumbens, tumor necrosis factor, system biology, anti-viral, anti-bacterial, molecular modeling
The global health landscape faces continuous challenges due to the emergence of infectious diseases caused by viral and bacterial pathogens. The need for therapeutics is of particular significance, considering the emerging trend of antibiotic resistance and the high rate of mutations exhibited by viruses. Medicinal plants traditionally provide a wealth of valuable secondary metabolites that have been historically used to treat many diseases. Tridax procumbens, called coat buttons, is a plant that has recently been predominantly studied based on the value it holds for its medicinal use (
The combination of systems biology and molecular modeling can be considered an effective method for understanding the interrelationships between components of biological systems. Systems biology enables the identification of systems-level properties for biological pathways and networks, thereby shedding light on how their component molecules interact. Molecular modeling, on the other hand, is a process through which the interactions among the molecules can be portrayed and simulated in a more realistic and precise manner at the atomic level (
The active compounds found in Tridax procumbens were identified through the Indian Medicinal Plants, Phytochemistry and Therapeutics, and KNApSAcK databases (
A GeneVenn diagram was constructed to highlight the common molecular targets between the active compound’s gene and target genes for viral and bacterial diseases. This tool helps visualize the overlap and relevance of these compounds in combating various pathogens.
We specifically used the Swiss Target Prediction server to identify the proteins with which our compounds interact. This server compares 2D and 3D chemical structures to predict the possible targets for the used compounds. Furthermore, we relied on the GeneCards and the Online Mendelian Inheritance in Man database (OMIM)(
To identify the targets, we mapped protein-protein interaction: Gene interaction on the STRING database: solid circles represent the genes, and the interconnected structures represent the proteins, as illustrated in Fig.
We used FunRich 3.1.3 to perform functional enrichment analysis of gene ontology, which includes studying biological pathways (BPA), cellular components (CC), and biological processes (BPR). This factor assists us in determining the role of genes in various contexts. Furthermore, we explored the Kyoto Encyclopedia of Genes and Genomes pathways for our chosen common gene. A p-value of less than 0.05 was used to determine statistical significance, indicating the importance of our gene ontology findings.
To evaluate how well the top target identified through the described topological analysis interacts with 29 selected bioactive compounds. As mentioned, three-dimensional structures of these compounds were retrieved from the PubChem database and then imported into Maestro, where they underwent energy minimization. As a result, a molecular database in.sdf format was created. Finally, the 3D structure of the TNF target protein was retrieved from the RSCB using PDB ID 2AZ5 (
We ran molecular dynamics simulations of this most promising molecule to know how it would behave under hypothesized biological conditions. In other words, these simulations show how the molecule behaves in the solvent environment. We simulated an orthorhombic box with a dimension of 12 Å on each side; the volume was optimized via the buffer size method. We used TIP3P and force-filed OPLS3e from Schrodinger Inc. standards for simulating proteins and ions16 for the standard water model. To mimic the physiological environment, we added sodium chloride (NaCl) to the system in a concentration of 0.15 M; we used sodium (Na+) and chloride (Cl-) ions (
A total of 309 compound targets of Tridax procumbens containing phytochemicals were obtained from the Swiss Target Prediction server. The additional targets linked to bacterial and viral infectious diseases were sourced from the Genecard and OMIM databases. As shown in Fig.
To determine the biological mechanisms of Tridax procumbens phytochemicals against viral and bacterial disease, we performed GO enrichment analysis on 126 potential therapeutic targets of Tridax procumbens phytochemicals used in the treatment of using the DAVID database (Fig.
In conclusion, the results of the gene ontology analysis provide valuable information on the dual anti-viral and anti-bacterial activity of Tridax procumbens. The overwhelming contribution of the processes that occurred in the cytoplasm and plasma membrane indicates that the action of this plant is primarily aimed at the cytoplasmic process and the functions associated with the membrane. The localization of the processes corresponds to the potential ways of the plant’s influence on the cell, likely through membrane integrity and intracellular signaling pathways.
In protein-protein interaction analysis, we performed a network-based analysis to determine the main factors involved in the dual anti-viral and anti-bacterial activity of Tridax procumbens. We analyzed which metrics could be used, such as out-degree, in-degree, clustering coefficient, average clustering coefficient, and protein-protein interaction visualization. We also viewed several statistics on the number of nodes in the network, network density, and shortest path length. The out-degree distribution is presented in the top left corner, and it resembles the in-degree distribution shown in the top right corner. Both charts depict a right-skewed pattern, meaning that most genes have fewer connections than a few genes with a high number of connections. This enables us to suppose that it has a scale-free network property with a small number of hub genes that have a lot of interactions with other genes (Fig.
Similarly, the average clustering coefficient on the bottom right chart decreases as neighbors increase. This means that although the highly connected nodes form a dense cluster, the overall network becomes less densely connected as it grows. It is possible that as more genes are included in the network, fewer new clusters of highly interconnected nodes are expected to form. The PPI network shows interaction between the top-ranked genes. The TNF node is the most top-ranked, with a score of 69. Other top hubs in the network include AKT1 with 64 and EGFR with 56, while SRC and ESR1 are equally ranked with a score of 55. The hub genes in the network have high connectedness points, making them at the center of the network. These hub genes are potential targets that Tridax Procumbens act upon to affect the anti-viral and anti-bacterial processes. The network statistics further expound on the structure and characteristics of the gene interaction network. The network has 125 nodes and 6 in diameter, with a density of 0.02 (Fig.
Another is epidermal growth factor receptor (EGFR), which is highly involved in regulating cell growth, survival, proliferation, and differentiation. The high centrality of this node within the network structure indicates that Tridax procumbens may affect cell-signaling pathways related to growth and proliferation. SRC and ESR1 are similarly highly expressed genes (
The KEGG pathway analysis of the TNF signaling pathway depicts numerous critical components and interactions influenced by the tumor necrosis factor. It plays a crucial role in several biological processes, such as inflammation, immune response, and apoptosis, and is associated with several key nodes and molecular interactions. TNF binds to its receptors, TNFR1 and TNFR2, and by recruiting adaptor proteins like TRADD, TRAF2, and RIP1, triggers multiple downstream signaling events. The activation of the MAPK and the NF-kappa B signaling pathways is triggered. In the MAPK pathway, the intermediaries from the top are TAK1, MEKK1, and MEK3/6, which activate JNK and p38 MAP kinases, which in turn activate transcription factors like AP-1, modulating the expression of pro-inflammatory genes (
The TNF signaling pathway shows its bifurcation capacity to induce apoptotic or survival signals. TNF can stimulate apoptotic cell death when it agitates complex formation with FADD and caspase-8, while in contrast, it can also agitate activation of NF-kappa B, producing anti-apoptotic proteins to enhance cell survival (
In conclusion, Tridax procumbens has immense potential as a medicinal plant to modulate the TNF signaling pathway, offering therapeutic potential. The compounds derived from T. procumbens probably inhibit TNF signaling from excessively overactivating, preventing excessive inflammation and subsequent tissue damage. Some bioactive compounds from T. procumbens could enhance certain aspects of TNF signaling, allowing the body to respond effectively against pathogens. Understanding the interaction of Tridax procumbens with the TNF pathway can also guide the development of new biomimetics that could have dual anti-bacterial and anti- viral potential in a balanced manner to avoid side effects. More so, the findings show an interplay of several signaling pathways and molecular functions, which might interconnect to enable T. procumbens therapies. The network analysis suggests TNF, AKT1, EGFR, SRC, and ESR1’s centrality, the probable target, and interaction for the T. procumbens dual anti-viral and anti-bacterial potential.
The molecular docking study was conducted to examine the anti-bacterial and anti-viral action of the Tridax procumbens derivatives. The study primarily included target proteins, and TNF was the particular focus. Ten phytochemicals from Tridax procumbens were used in the study. The results confirmed that these phytochemicals had better binding affinities over others on the target genes. The reported 5,7,2,3,4-pentahydroxy-3,6-dimethoxyflavone 7-glucoside compound showed a binding affinity value close to the co-crystal ligand on the TNF gene. The docking score of the same was found to be -2.308. Cynaroside was observed to have a highly remarkable binding affinity value of -8.157 in docking, whereas the other compound 5,7,2,3,4-Pentahydroxy-3,6-dimethoxyflavone 7-glucoside also showed the highly prominent binding affinity value of -8.371. Moreover, isoquercitrin also had a significant docking value of -7.016 in the binding site (Table
Compound | Dock Score | Compound | Dock Score |
---|---|---|---|
5,7,2, ‘,3’,4’-Pentahydroxy-3,6- dimet hoxyflavone 7-glucoside | -8.371 | Lupeol | -1.821 |
Cynaroside | -8.157 | 14-Ketostearic acid methyl ester | -1.661 |
Isoquercitrin | -7.016 | Olean-12-en-3-one | -1.612 |
Tridaxidone | -6.768 | beta-Amyrone | -1.612 |
Quercetin | -5.505 | Docosanoic acid | -1.553 |
6-Hydrox yluteolin 6,3’-dimethyl eter 5-rhamnoside | -5.412 | beta-Amyrin | -1.148 |
Luteolin | -5.129 | Arachidic acid | -0.674 |
Stigmasterol | -3.095 | Myristic acid | -0.521 |
beta-Sitosterol | -2.913 | Dotriacontanol | -0.102 |
Campesterol | -2.659 | Linoleic acid | 0.117 |
(24E)-2 4-N-Propylidenecholestero l | -2.466 | Stearic acid | 0.297 |
Coc-crystal ligand | -2.308 | Dotriacontane | 0.425 |
9-Heptadecanone | 1.261 | 29-Dotriacontenoic acid, 30-methyl-8-oxo- | 0.569 |
Linolenic acid | 1.432 | Palmitoleic_acid | 0.676 |
Lauric acid | 3.017 | Palmitic acid | 0.82 |
A more detailed picture of these interactions was obtained. Thus, three hydrogen bonds were observed for compound 5,7,2’,3’,4’-pentahydroxy-3,6-dimethoxyflavone 7-glucoside with the TNFG target gene: one bond with Gly148 and Gln149 through 4th and 5th OH groups on the tetrahydro-2H-pyran moiety and Leu120 with the OH group of the benzene ring (Fig.
In order to better understand the interaction of the compounds with the target protein, we generated a 150 ns molecular dynamics simulation using DESMOND software. The compounds studied here are TNF-bound with 5,7,2’,3’,4’-pentahydroxy-3,6-dimethoxyflavone 7-glucoside, TNF/cynaroside, and TNF in a co-crystal ligand. The parameters followed in this study are RMSD, root-mean-square fluctuation, and protein-compound interactions.
For compound cynaroside, the RMSD values of the C-alpha atoms within the protein complex stabilized at about 80 nanoseconds and became stable at 0.8 Å throughout the rest of the simulation (Fig.
A. The hit compound cynaroside targeted the TNF protein complex using molecular dynamics (MD) simulation evaluation. The top left image shows the root mean square deviation (RMSD), with the RMSD of proteins in blue and the compound in red. The up-right image presents a heat map analysis for protein-ligand complexes. The middle-left image represents individual amino acids’ root mean square fluctuation (RMSF) within proteins. The bottom image has a two-dimensional (2D) interaction diagram that maps interactions between the compound and the protein; B. The hit compound 5,7,2,3,4-Pentahydroxy-3,6-dimethoxyflavone 7-glucoside targeted the TNF protein complex using molecular dynamics (MD) simulation evaluation. The top left image shows the root mean square deviation (RMSD), with the RMSD of proteins in blue and the compound in red. The up-right image presents a heat map analysis for protein-ligand complexes. The middle-left image represents individual amino acids’ root mean square fluctuation (RMSF) within proteins. The bottom image has a two-dimensional (2D) interaction diagram that maps interactions between the compound and the protein; C. Co-crystal ligand analysis of the TNF protein complex through molecular dynamics (MD) simulation. In the top left picture, the root mean square deviation (RMSD) is blue for the protein and red for the ligand. The top right image shows a heatmap analysis of the protein-ligand complex. The middle left figure demonstrates root mean square fluctuation (RMSF) for amino acids in proteins individually. The lower image is a two-dimensional (2D) interaction diagram illustrating interactions between ligands and proteins.
Regarding interactions, 5,7,2,3,4-Pentahydroxy-3,6-dimethoxyflavone 7-glucoside formed three hydrogen bonds with TNF protein residues, including Tyr119, Gly121, and Tyr151. The role in hydrophobic interactions involved residues such as Tyr59, Ala96, Leu94, Ile118, and Ile155 (Fig.
The interaction analysis for cynaroside showed three hydrogen bonds with residues Tyr119, Gly121, and Ser60, with the latter interacting through a water bridge with the OH group of the octahydro-2H-chromene moiety, as shown in figures (Fig.
Integrating systems biology and molecular modeling in this study has provided valuable insights into the dual anti-viral and anti-bacterial potential of Tridax procumbens, particularly through its interaction with the Tumor Necrosis Factor (TNF) signaling pathway. We adopted a multi-pronged strategy involving bioinformatics, molecular docking, and molecular dynamics simulations focusing on bioactive compounds from the plant Tridax procumbens. It is important to understand the role of the TNF signaling pathway in regulating immune responses, inflammation, and cell survival. TNF activates the signaling pathways through its receptors, TNFR1 and TNFR2, and activates several downstream signaling cascades, such as the MAPK and the NF-κB pathway. These pathways are responsible for the functional expression of genes associated with inflammation, immunity, and apoptosis. We reported molecular docking studies, which indicated that TNF binds to compounds like cynaroside and 5,7,2,3,4-Pentahydroxy-3,6-dimethoxyflavone 7-glucoside with docking scores of -8.157 and -8.371, respectively. These scores favor their ability to regulate TNF activity.
The protein-protein interaction (PPI) network analysis identified nodes like TNF, AKT1, EGFR, SRC, and ESR1 as key components of the anti-viral and anti-bacterial mechanisms of Tridax procumbens. The further GO enrichment analysis also showed the molecules involved in the biological processes, cellular components, and molecular functions influenced by these compounds. Interestingly, the significantly enriched genes regulated by T. procumbens are mainly engaged in the cytoplasm and plasma membrane, which can support the potential mechanisms by which T. procumbens may act at the cellular level by altering the membrane integrity and signal transduction. The insights offered by the molecular dynamics simulations also enabled a greater understanding of the stability and behavior of these compounds within the TNF binding pocket when conditions are closer to the physiological conditions. For example, cynaroside kept the same RMSD values and had consistent hydrogen contact with some residues of TNF protein, which showed stable and robust interaction. Likewise, 5,7,2,3,4-Pentahydroxy-3,6-dimethoxyflavone-7-glucoside established stable interactions and showed slower fluctuations than other compounds with therapeutic potential.
Although our findings are promising, the study has limitations. The first drawback is that computational prediction is done without in vitro testing. Though these methods give preliminary solid data, future research will focus on in vitro and in vivo research to establish the effectiveness and safety of these bioactive compounds. The bioavailability and toxicity of these compounds will be important considerations for formulating them as potential therapeutic agents. Further studies examining potential mechanisms of action and possible synergistic combinations with anti-viral and anti-bacterial drugs may be beneficial in generating additional therapeutic opportunities to improve treatment outcomes.
This study shows that Tridax procumbens could be an essential plant source of new bioactive compounds with dual anti-viral and anti-bacterial activity. Using molecular modeling and systems biology, we explored several vital molecules targeting the TNF signal transduction cascade, an essential immunological mediator in inflammation. The findings provide a foundation for further research into the therapeutic applications of Tridax procumbens, highlighting its promise in addressing the global challenge of infectious diseases. Additional research will include toxicological studies and bioassays in vitro and in vivo to assess these bioactive compounds’ possible therapeutic efficacy and toxicity. The findings of this study not only offer to explore the potential of Tridax procumbens containing phytochemicals and open new opportunities for exploring new molecules for anti-viral and anti-bacterial infections. We intend to perform the in vitro validation in our upcoming study. Further research and validation will lead to recognizing Tridax procumbens containing phytochemicals as essential bioactives in managing infectious diseases.
Conflict of interest
The authors have declared that no competing interests exist.
Ethical statements
The authors declared that no clinical trials were used in the present study.
The authors declared that no experiments on humans or human tissues were performed for the present study.
The authors declared that no informed consent was obtained from the humans, donors or donors’ representatives participating in the study.
The authors declared that no experiments on animals were performed for the present study.
The authors declared that no commercially available immortalised human and animal cell lines were used in the present study.
Funding
No funding was reported.
Author contributions
Muthanna Saadi Farhan: Conceptualized the study, performed the system biology analysis, and contributed to writing and editing the manuscriptAND , and supervised the entire project.
Farrah Rasool Jaafar: Conducted the molecular modeling experiments, analyzed the data, and drafted the initial manuscript.
Amjad I. Oraibi: Provided critical feedback, revised the manuscript for important intellectual content.
All authors have read and approved the final manuscript.
Data availability
All of the data that support the findings of this study are available in the main text.